We assessed audiovisually induced erections after nerve block of the neurovascular bundle during prostate biopsy. We evaluated neurovascular bundle nerve block to mimic non-nerve-sparing radical prostatectomy in an experimental setup. Patients undergoing a transrectal ultrasoundguided prostate biopsy were randomized to bilateral injection of 5 ml ropivacaine hydrochloride 0.75% or NaCl 0.9% into the neurovascular bundle. The patients completed the International Index of Erectile Function 5-item questionnaire (IIEF-5) questionnaire, and a detailed patient history was obtained. A routine prostate biopsy was performed. Thereafter, patients were exposed to 60 min of audiovisual stimulation. Erections were recorded using a Rigiscan-Plust device. A total of 11 patients were randomized. Five patients received NaCl (group 1) and six patients ropivacaine (group 2). Patient characteristics were comparable in terms of age (group 1: 59.8 y; group 2: 61.8 y), mean PSA (4.1 vs 4.7 ng/ml), mean IIEF-5 score (20.5 vs 22) and risk factors for erectile dysfunction, respectively. Patients of group 1 showed significantly stronger and longer erections after audiovisual stimulation than patients in group 2. Patients with bilateral infiltration of saline solution to the neurovascular bundle showed significantly stronger erections than patients receiving local anesthesia of the neurovascular bundle. Thus, this experiment might serve as a model to assess postoperative erectile function after a unilateral nerve-sparing radical prostatectomy.
Introduction
Erectile dysfunction (ED) following radical prostatectomy has a considerable impact on the quality of life, especially in younger patients. 1 Therefore, preservation of erectile function after radical prostatectomy is of great interest. Patient selection for a nerve-sparing operation is currently still under debate. Mainly oncological parameters such as PSA, biopsy Gleason score, number of positive biopsy scores and others are used to select patients for a nerve-sparing procedure. While trying to preserve erectile function, the main goal of radical prostatectomy, namely maximal cancer control, should not be hampered. An anatomical, that is, nerve sparing, surgery improves postoperative erectile function. 2 A bilateral nerve-sparing procedure should be performed because reported results for unilateral procedures are less favorable. 3, 4 However, the variability of published results especially for unilateral nervesparing procedures is substantial. 5, 6 Differences in study design, patient selection, retrospective character of studies, and also the surgeon's experience, contribute largely to the wide range of reported results. 4 So far, no objective measures have been available to assess the true impact of unilateral nervesparing on postoperative erectile function in men after radical prostatectomy. Therefore, we evaluated whether it is possible or not to mimic a non-nervesparing radical prostatectomy when anesthetizing the neurovascular bundle for prostate biopsy. We report on the preliminary results of a model to evaluate the potential postoperative erectile function after a nonnerve-sparing procedure either unilateral or bilateral.
Patients and methods
Male patients undergoing a transrectal ultrasound (TRUS)-guided prostate biopsy were included. The study was conducted in accordance with the Helsinki declaration of good clinical practice guidelines. The study was approved by the local ethical committee. Exclusion criteria were patient age 470 y, bleeding disorders, severe pulmonary or cardiac diseases or known allergies to local anesthetics and antibiotics. Prior to prostate biopsy, patients completed the International Index of Erectile Function 5-item questionnaire (IIEF-5). 7 In addition, a complete medical history was taken with special attention to the risk factors for ED.
TRUS, application of local anesthetics or saline solution, and prostate biopsy were performed in the lithotomy position using a 6.5 MHz probe (Hitachi, Zug, Switzerland). For the present study, ropivacaine hydrochloride 0.75% (Naropin s , AstraZeneca, Zug, Switzerland), a long-lasting local anesthetic, was used. Application of ropivacaine hydrochloride was performed under TRUS guidance using a 22-gauge needle (spinal needle 22G, Becton Dickinson AG, Basel, Switzerland) through the biopsy guide with duplex monitoring (Figure 1a and b). In a single blinded fashion, patients received either 5 ml of saline solution or ropivacaine hydrochloride on both sides dorsolateral to the prostate base at the supposed site of the neurovascular bundles. 8 After the biopsy, the patients had a rest of 30 min in a secluded room. Thereafter, blood pressure and heart frequency were recorded and a Rigiscan-Plust was mounted (NPT-100, Nipro Co. Ltd, Miami, FL, USA). Patients were exposed to audiovisual sexual stimulation (AVSS) for 60 min and penile tumescence and rigidity were recorded.
Results
A total of 11 patients were randomized. Five patients received NaCl (group 1) and six patients ropivacaine (group 2). Patient characteristics were comparable in terms of mean age (group 1 59.8 y, group 2 61.8 y), mean PSA (4.1 vs 4.7 ng/ml), mean IIEF-5 score (20.5 vs 22) and risk factors for ED, respectively. In each group, one prostate cancer was detected. Patients of group 1 showed stronger and longer erections under AVSS than patients in group 2. Average event duration in group 1 was 16 min (range 11-18 min), with an average rigidity of 50% at base and tip, and on average two events per session. In group 2, the average event duration was 2 min (range 0-8 min) resulting from one patient who had a rigidity event lasting 8 min with an average rigidity of 35%. Mean tumescence (difference in penile circumference) increased 3.4 cm at penile base and 4.1 cm at penile tip in group1 under AVSS. In group 2, tumescence changes were 0.4 cm at base and 0.2 cm at tip, mainly because of the same patient being responsible for the rigidity changes. Automated analysis by Rigiscan-Plust software similarly showed results in favor of group 1, and the results are presented in Table 1 .
Discussion
The data of our preliminary study indicate that it is possible to mimic non-nerve-sparing radical prostatectomy by anesthetizing the neurovascular bundle reversibly during prostate biopsy. Patients receiving Figure 1 Site of injection between rectum and prostate with duplex visualization of neurovascular bundle before (a) and after (b) application of ropivacaine. Postoperative erectile function after radical prostatectomy RT Strebel et al ropivacaine showed no tumescence or rigidity increases considered strong enough for vaginal penetration during AVSS. In contrast, patients with infiltration of the neurovascular bundle with saline solution showed a good quality of erections. Therefore, we suggest that we established a model to assess the possible postoperative erectile function after a non-nerve-sparing radical prostatectomy when anesthetizing the neurovascular bundles. The published data in the literature clearly show that patients undergoing a nerve-sparing prostatectomy may expect-at least to some degree-a preservation of erectile function. 5 In contrast, patients after wide resection of the neurovascular bundle usually suffer from more severe ED. 9 However, it is not known to which degree the erectile function truly can be preserved when performing an anatomical bilateral nerve-sparing prostatectomy. This is even more true for a unilateral procedure.
Our study has some limitations. First of all, no double-blinded infiltrations were performed. Being a feasibility study, this was not intended. Furthermore, the number of patients in each group was small. The study group might also not represent the population at risk, because only two out of 11 had prostate cancer. Undiagnosed early-stage prostate cancer per se however is not known as an independent risk factor for ED, and therefore patient selection probably did not influence our study results. We considered associated psychological and somatic distress after prostate biopsy as possible bias, but surprisingly patients had no difficulties in getting erections immediately after the procedure. Conversely, during the prostate cancer diagnosing process, no differences in emotional distress were found in patients with or without confirmed prostate cancer. 10 Confirmed diagnosis and treatment of prostate cancer however can lead to psychological distress. Several studies suggest that psychological distress is greatest in patients with localized prostate cancer close to diagnosis, and decreases thereafter continuously.
11,12 Therefore, we do not believe that psychological factors did confound our results. To investigate a possible bias of the prostate biopsy, we asked two patients (one from each group) to undergo additional Rigiscan Plust recordings with AVSS 1 week after the prostate biopsy. Both patients showed a good erectile response. Thus, prostate biopsy might have a quantitative rather than a qualitative effect on the results of Rigiscan Plust recordings. There are other postoperative factors that might influence postoperative erectile function which are not being addressed with our experiment. Mulhall and Graydon 13 suggest that injury to the accessory pudendal arteries can decrease the arterial inflow to the corpora cavernosa, thus being a significant cofactor for an impaired postoperative erectile function. However, the results of our feasibility study encourage us to perform a double-blinded, placebo-controlled study with uni-or bilateral infiltration of the neurovascular bundle with local anesthetics or saline solution. As an extension of the protocol, every patient will be asked to undergo an additional AVSS 10 days after the prostate biopsy to assess this possible bias. This will allow us to elucidate to which degree erectile function can be preserved after a unilateral nerve-sparing radical prostatectomy. Moreover, the indication for patient selection in nerve-sparing procedures might be elucidated when considering not only oncological parameters but also general risk factors for ED in decisionmaking.
